Loading...
By the Editors
This week, early studies of treatments for novel coronavirus disease (COVID-19) showed promise for both hydroxychloroquine and convalescent plasma from patients who'd been symptom-free for 10 days. In terms of prevention, a vaccine candidate elicited an immune response in rodents within 2 weeks. And elsewhere, new data emerged on presymptomatic transmission of SARS-CoV-2. To catch up on these and other COVID-19 stories, follow the links below.
Comment
LINK(S):
COVID-19: Early Vaccine Results / Blood Donation Changes / Environmental Contamination (Apr. 2) (Free)
COVID-19 Update: Hydroxychloroquine & Recovery Time / Home Face Masks at Work / Reusing Respirators (Apr. 1) (Free)
SARS-CoV-2 Readily Shed Early in Infection, Transmissible Before Symptoms Emerge (Apr. 1) (Free)
COVID-19: Crisis Standards of Care / Face Masks in Public / Conjunctivitis (Mar. 31) (Free)
COVID-19 Update: Viral Persistence in Sputum & Feces / ACE Inhibitors & ARBs / Malaria Drug Emergency Authorization (Mar. 30) (Free)
Early Results Promising for Convalescent Plasma for COVID-19 (Mar. 29) (Free)
COVID-19: Skilled Nursing Facilities / Rapid Test / After Symptoms Resolve (Mar. 29) (Free)